ArticleEClinicalMedicine2026
Post-pandemic respiratory infections in children born during or before the COVID-19 pandemic: a nationwide cohort study in Sweden.
Article in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic altered the circulation of respiratory pathogens. Following an initial decline in infections, a resurgence occurred as restrictions eased. We aimed to determine whether reduced early-life exposure to pathogens increased the risk of severe respiratory infections. Methods: In this longitudinal nationwide population-based study in Sweden, we compared a pandemic birth cohort of children born in Sweden between March 1 and December 31 from 2020 (n = 92,791) with aligned pre-pandemic cohorts born between 1 March and December 31 of 2015 (n = 94,552) and of 2018 (n = 96,074). Children with missing covariate data, death, or emigration before the age of two were excluded (10·5%). Baseline characteristics for the first two years of life were summarized. Outcomes were assessed between ages 2-4 years. Hospitalization for overall and specific lower respiratory tract infections (LRTI) was analysed as a binary outcome using logistic regression. Findings: Children born in 2020 had markedly lower hospitalisation rates during their first two years of life than both pre-pandemic cohorts. However, between ages 2 and 4, they exhibited significantly higher hospitalisation risk compared with both pre-pandemic cohorts. Adjusted odds ratio (aOR) for hospitalisation in the 2020 versus 2015 cohort were: all-cause LRTI (2·51 (95% CI 2·26-2·79)), influenza (2·99, 2·38-3·79) and respiratory syncytial virus (RSV) (4·36, 3·60-5·31). Similar patterns were observed for all-cause pneumonia and mycoplasma. The 2018 cohort showed a more mixed pattern, with lower risk for pneumonia but higher risk for RSV. Interpretation: Children born during the COVID-19 pandemic initially had a reduced risk of hospitalisation for respiratory infections, followed by a substantially increased risk in the post-pandemic period compared to children born before the pandemic. These findings suggest that altered early-life microbial exposure due to pandemic-related restrictions may influence subsequent patterns of severe childhood infections through immunological or exposure-related mechanisms and emphasis the need for further research to elucidate underlying mechanisms. Funding: The SCIFI-PEARLS project has basic fundings from the Swedish government and the county councils, the ALF agreement, the Swedish Research Council for Health, Working Life and Welfare, (Forte), and previously a joint grant from Forte-and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.